Home » Media Center » News » Gornitzky represents a Chinese Investment Fund in a USD 5 million investment.
December 29, 2014

Gornitzky represents a Chinese Investment Fund in a USD 5 million investment.

Gornitzky represented Shanghai GEOC Hengtong Investment Limited Partnership, a Chinese investment fund, and its affiliate, Fortune China Ltd. in a USD 5 million investment in Vascular Graft Solutions Ltd.

Vascular Graft Solutions Ltd. is a developer of innovative solutions to improve the outcome of bypass surgery and patients’ quality of life.

Shanghai GEOC Hengtong Investment Limited Partnership and Fortune China Ltd. were represented by Timor Belan (Partner) and Assaf Harel.

KEY CONTACTS

RELATED PRACTICES

RELATED NEWS & PUBLICATIONS

News

Hilton forecloses assets of businessman Michel Ohayon, amounting to approximately NIS 100 million
News

Egged Transportation Company Ltd. – Approval of a distribution that does not meet the profits test
News

The International Arbitration team has been listed in the GAR 100 list.
News

Gornitzky represented IFF in its sale of its Cosmetic Ingredients Business for approximately US $810 million.
News

Gornitzky represented JonesTrading in BioLineRx’s USD 6 million registered direct offering on Nasdaq
News

Our firm represented KNAPP in a commercial transaction with the public company Fox Wizel Ltd
News

Our firm advised the independent committee of Ayalon Insurance Company Ltd.
News

Nuna Lerner was appointed as the Chairperson of the Arbitration Committee of the International Chamber of Commerce (ICC) in Israel.
News

Antitrust Webinar
News

Appointment of Keren Reichbach Segal as a trustee for the Alaska Shefa Ltd.
News

Pituach the Financing and Investment Trust v. Shapira et al.
News

Representation of Netuv Management & Development Co. Ltd. in a claim for the dissolution of a real estate partnership.
All Publications
Hit enter to search or ESC to close